HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

resorufin

Networked: 32 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1. De-Oliveira, Ana C A X: 2 articles (08/2009 - 01/2008)
2. Paumgartten, Francisco J R: 2 articles (08/2009 - 01/2008)
3. Benavides, Tomas: 2 articles (12/2008 - 09/2004)
4. Clapés, Pere: 2 articles (12/2008 - 09/2004)
5. Clothier, Richard: 2 articles (12/2008 - 09/2004)
6. Infante, María Rosa: 2 articles (12/2008 - 09/2004)
7. Mitjans, Montserrat: 2 articles (12/2008 - 09/2004)
8. Vinardell, María Pilar: 2 articles (12/2008 - 09/2004)
9. Liu, Jinying: 1 article (02/2022)
10. Lu, Xiaoyan: 1 article (02/2022)

Related Diseases

1. Body Weight (Weight, Body)
01/01/1991 - "4. The microsomes contained about 43 pmol P-450/mg protein corresponding to 0.51 nmol P-450/g midgut and 64 pmol P-450/g body weight, respectively, and converted benzyloxyresorufin into resorufin with a Vmax of 2.12 pmol resorufin/min.mg protein and a Km of 770 nM benzyloxyresorufin at 25 degrees C, pH 8.0. "
03/01/2004 - "Increased liver-to-body weight ratios coincided with a significant induction of uridinediphosphate-glucuronosyltransferase (UDGPT; two to four-fold), and ethoxy- and pentoxy-resorufin-O-deethylase (EROD and PROD) at the two highest doses in all exposures. "
03/01/1993 - "The induction of hepatic P450 2B protein and ethoxy-, pentoxy-, and (benzyloxy)resorufin O-dealkylation activities, and epoxide hydration activity and liver/body weight ratio increase were examined in male F344/NCr rats fed the various congeners for 14 days at doses equimolar to 500 ppm phenobarbital. "
01/15/1990 - "In the guinea pig, 5 days after treatment with TCDD at 10 micrograms/kg, TCDD toxicity was also evident (loss of body weight and thymus weight); there was no change in DT-diaphorase as measured by resorufin reduction, confirming by a different assay the observation of Beatty and Neal (Biochem Pharmacol 27: 505-510, 1978) that TCDD does not induce DT-diaphorase in guinea pig liver, and 7-EROD was increased 8-fold. "
01/01/2017 - "The present study investigated whether treatment with MA (300 mg Sb5+/kg body weight/day, subcutaneously) for 24 days affected the activities of cytochrome P450 (CYP)1A (ethoxyresorufin- O-deethylase), CYP2A5 (coumarin 7-hydroxylase), CYP2E1 ( p-nitrophenol-hydroxylase), CYP2B9/10 (benzyloxy-resorufin- O-debenzylase), or CYP3A11 (erythromycin- N-demethylase) in the livers of Swiss Webster (SW) and DBA-2 male and female mice. "
2. Parasitemia
3. Starvation
4. Infections
5. Neoplasms (Cancer)

Related Drugs and Biologics

1. Mixed Function Oxygenases (Monooxygenases)
2. Cytochrome P-450 CYP1A1 (CYP1A1)
3. Cytochrome P-450 CYP3A
4. Cytochrome P-450 CYP2E1 (CYP2E1)
5. 4-nitrophenol
6. Cytochrome P-450 Enzyme System (Cytochrome P450)
7. Uridine
8. Transferases
9. Enzymes
10. resazurin

Related Therapies and Procedures

1. Aftercare (After-Treatment)